The Science Behind Your Choice: Mechanisms and Availability
What Is Better Mounjaro or Wegovy: Current UK Stock Availability
The question of availability has historically favoured Mounjaro, as Wegovy experienced significant supply constraints throughout 2023 and early 2024. However, the landscape has dramatically improved for UK patients seeking Wegovy. EverydayMeds maintains reliable stock levels of all five Wegovy doses (0.25mg through 2.4mg) with direct supply agreements from Novo Nordisk. This means patients can now access both treatments without delays, making the choice purely clinical rather than availability-driven.
When comparing what is better Mounjaro or Wegovy from a practical standpoint, both are now readily available for next-day delivery across the UK. Our cold-chain logistics ensure your prescription-only medicine arrives in optimal condition, whether you choose Wegovy's proven GLP-1 approach or prefer to explore Mounjaro's dual-receptor mechanism through alternative providers. The key advantage is having genuine choice again, rather than being forced into one option due to supply issues.
Wegovy vs Mounjaro Pricing: Value Comparison for UK Patients
Pricing transparency helps answer what is better Mounjaro or Wegovy from a financial perspective. EverydayMeds Wegovy pricing starts at £79.99 for the 0.25mg starter dose (with new customer code FIRST40), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our bundle options, such as the Intro Duo (0.25mg & 0.5mg) at £169.99, provide convenient two-month starter packages. Returning customers benefit from code DOSE25 at checkout.
While Mounjaro pricing varies between providers, Wegovy's established market presence has created more predictable costs for budgeting purposes. The question of what is better Mounjaro or Wegovy often comes down to your individual insurance coverage and monthly budget allocation. Both treatments represent significant investments in long-term health, but Wegovy's longer market presence has generally resulted in more competitive pricing across UK pharmacies, including our transparent fee structure at EverydayMeds.
Clinical Evidence: Understanding What Is Better Mounjaro or Wegovy
The clinical evidence base differs significantly between these treatments, making direct comparisons complex. Wegovy's efficacy stems from the landmark STEP trials, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks when used alongside a reduced-calorie diet and increased physical activity (Wilding et al., NEJM, 2021). The STEP programme also showed sustained results at two years, with STEP 5 maintaining ~clinically studied weight loss, plus cardiovascular benefits in the SELECT trial.
Mounjaro's evidence comes from different trial populations and methodologies, making head-to-head percentage comparisons inappropriate. When evaluating what is better Mounjaro or Wegovy, focus on individual suitability rather than raw percentages. Both are prescription-only medicines requiring clinical assessment, and your prescriber can determine which mechanism—Wegovy's targeted GLP-1 action or Mounjaro's dual-receptor approach—aligns better with your medical profile and treatment goals.
How Wegovy Works in Your Weight Management Journey
Understanding Wegovy's mechanism helps clarify what is better Mounjaro or Wegovy for your specific needs. Wegovy (semaglutide) is a GLP-1 receptor agonist that mimics your body's natural incretin hormone, which normally rises after eating to signal fullness. By targeting these specific brain receptors, Wegovy may help reduce appetite and promote earlier satiety during meals. This can lead to naturally smaller portion sizes without the psychological struggle of traditional restrictive dieting. The once-weekly injection schedule via FlexTouch pen provides consistent therapeutic levels, and the gradual dose escalation from 0.25mg to 2.4mg helps minimise initial side effects whilst building tolerance.
Your EverydayMeds Wegovy Ordering Process
Accessing Wegovy through EverydayMeds involves a streamlined three-step process designed for busy lifestyles. Your journey begins with a comprehensive three-minute online clinical assessment covering medical history, current medications, and weight management goals. Our qualified prescribers (GPhC #9012878) then review your application, typically within three working days, though express 24-hour review is available for urgent requirements. Once approved, your prescription-only medicine ships via next-day delivery using specialised cold-chain packaging to maintain the required 2-8°C temperature range until it reaches your door.
Storage and Practical Considerations: Wegovy's Travel Advantage
One practical factor when deciding what is better Mounjaro or Wegovy involves storage flexibility, particularly for frequent travelers. Wegovy offers superior convenience with up to six weeks of room temperature storage (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day limit. This makes Wegovy more suitable for extended business trips, holidays, or situations where refrigeration isn't immediately available. The FlexTouch pen system is intuitive for self-administration, and the once-weekly schedule means fewer injection days compared to daily medications. Each dose escalation phase lasts four weeks, providing ample time to assess tolerance before progressing to higher strengths.
What Is Better Mounjaro or Wegovy: UK-Specific Availability Factors
The UK medical landscape has created unique considerations when evaluating what is better Mounjaro or Wegovy. NICE guidance TA875 specifically recommends Wegovy alongside specialist weight management support, potentially influencing NHS funding decisions in some regions. The MHRA's approval timeline also differs, with Wegovy having longer real-world UK usage data to inform safety monitoring and clinical experience among UK prescribers.
EverydayMeds' focus on Wegovy reflects both demand patterns and supply chain reliability within the UK market. While both treatments serve similar patient populations, Wegovy's established distribution network through Novo Nordisk provides greater confidence in consistent availability. This reliability factor often influences the what is better Mounjaro or Wegovy decision, as treatment continuity is essential for sustained weight management outcomes and avoiding metabolic disruption from forced medication switches.
Making Your Decision: Expert Support and Next Steps
Rather than declaring what is better Mounjaro or Wegovy definitively, the optimal choice depends on your individual medical profile, lifestyle factors, and treatment preferences. Both treatments are available from EverydayMeds—your prescriber can help determine which is right for you based on your health history and weight management goals. Our clinical team (GPhC #9012878) considers factors like your travel requirements, injection preference, previous medication responses, and budget constraints during the assessment process. New customers can start their Wegovy journey with code FIRST40, while returning patients use DOSE25 at checkout. Begin your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy to access next-day delivery across the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
